ACP Journal Club: review: telaprevir, boceprevir, simeprevir, or sofosbuvir improves response in HCV type 1.
Ronald L
RL
Koretz
D000998:Antiviral Agents / Q000627:therapeutic use*; D016174:Hepacivirus / Q000502:physiology*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans
D000998:Antiviral Agents